CNC vs CVS
CNC: A leading provider of government-sponsored healthcare programs, focusing on Medicaid, Medicare, and the Health Insurance Marketplace. CVS: A leading health solutions company integrating retail pharmacy, pharmacy benefit management, and insurance services to manage health costs and improve access to care.
Side-by-side fundamentals
| Metric | CNC | CVS | Edge |
|---|---|---|---|
| Price as of 2026-10-09 close | $65.36 | $86.16 | |
| Market cap | $32.3B | $110.2B | |
| P/E as of 2026-10-09 | n/a | 22.84 | |
| Net margin FY2025, SEC XBRL | -3.4% | +0.4% | CVS higher |
| Gross margin FY2025, SEC XBRL | +7.3% | n/a | |
| Operating margin FY2025, SEC XBRL | -3.9% | +1.2% | CVS higher |
| ROE FY2025, SEC XBRL | -33.3% | +2.4% | CVS higher |
| ROA FY2025, SEC XBRL | -8.7% | +0.7% | CVS higher |
| Debt / equity as of 2026-09-03 | 0.71 | 0.77 | CNC lower |
| Revenue growth (YoY) as of 2026-09-03 | +17.0% | +7.4% | CNC higher |
| Revenue CAGR (3y) SEC XBRL | +10.5% | +7.6% | CNC higher |
| Dividend yield as of 2026-09-03 | n/a | +3.0% | |
| Dividend streak (yrs) SEC XBRL | 0 | 19 | CVS higher |
| Beta as of 2026-09-03 | 0.18 | 0.28 | |
| 1-year return as of 2026-10-09 close | +72.8% | +12.3% | CNC higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.